Chime Biologics Receives “China Best Biologics CMO of the year” Award from IMAPAC

On July 8^th 2020, the well-known consulting firm IMAPAC held a ceremony “Asia-Pacific Bioprocessing Excellence Awards 2020”and announced that Chime Biologics has received the “China Best Biologics CMO of the year” award for its great performance in 2019.

The Asia-Pacific Bioprocessing Excellence Awards” aims to celebrate outstanding bioprocessing experts, organizations, and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost and superior quality. Chime Biologics is honored to be recognized by IMPAC as “China Best Biologics CMO of the year”.In the future, Chime Biologics will commit to deliver client-dedicated contract development and manufacturing services with the greater quality, speed, efficiency and state-of-the-art capability in the thriving and dynamic biologics market to make world-class biopharmaceuticals affordable and accessible to all patients globally through manufacturing innovation.